170 related articles for article (PubMed ID: 36528563)
1. Recent hospitalization and risk of antidepressant initiation in people with Parkinson's disease.
Hämäläinen I; Tiihonen M; Hartikainen S; Tolppanen AM
BMC Geriatr; 2022 Dec; 22(1):974. PubMed ID: 36528563
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease.
Pirttilä A; Tiihonen M; Paakinaho A; Hartikainen S; Tolppanen AM
J Am Med Dir Assoc; 2023 Sep; 24(9):1290-1296.e4. PubMed ID: 37220871
[TBL] [Abstract][Full Text] [Related]
3. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease.
Tarvainen A; Hartikainen S; Taipale H; Tanskanen A; Koponen M; Tolppanen AM
Int J Geriatr Psychiatry; 2021 Jul; 36(7):1075-1084. PubMed ID: 33527403
[TBL] [Abstract][Full Text] [Related]
4. Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study.
Hentilä E; Tiihonen M; Taipale H; Hartikainen S; Tolppanen AM
BMC Geriatr; 2021 Mar; 21(1):202. PubMed ID: 33757451
[TBL] [Abstract][Full Text] [Related]
5. Use of antidepressants and the risk of Parkinson's disease: a prospective study.
Alonso A; Rodríguez LA; Logroscino G; Hernán MA
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):671-4. PubMed ID: 19448091
[TBL] [Abstract][Full Text] [Related]
6. A nationwide study of initiation of antidepressant pharmacotherapy and the risk of seizures.
Wiggs KK; Lagerberg T; Quinn PD; Öberg AS; Larsson H; Chang Z; D'Onofrio BM
Epilepsy Res; 2023 May; 192():107134. PubMed ID: 37037097
[TBL] [Abstract][Full Text] [Related]
7. Recent Hospitalization and Initiation of Antiepileptics Among Persons With Alzheimer's Disease.
Elo J; Tolppanen AM; Koponen M; Tiihonen M; Hartikainen S
J Am Med Dir Assoc; 2023 Feb; 24(2):213-219.e6. PubMed ID: 36403662
[TBL] [Abstract][Full Text] [Related]
8. Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.
Paakinaho A; Koponen M; Tiihonen M; Kauppi M; Hartikainen S; Tolppanen AM
Neurology; 2022 Mar; 98(12):e1273-e1281. PubMed ID: 35064025
[TBL] [Abstract][Full Text] [Related]
9. Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study.
Zenesini C; Baldin E; Vignatelli L; Poluzzi E; Antonazzo I; Calandra-Buonaura G; Guarino M; De Carolis P; Cortelli P; D'Alessandro R;
J Neurol Sci; 2019 Oct; 405():116421. PubMed ID: 31422283
[TBL] [Abstract][Full Text] [Related]
10. Use of antidepressants in Parkinson's disease: A Swedish register-based study of over 1.5 million older people.
Haasum Y; Fastbom J; Johnell K
Parkinsonism Relat Disord; 2016 Jun; 27():85-8. PubMed ID: 27117031
[TBL] [Abstract][Full Text] [Related]
11. Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs.
Gony M; Lapeyre-Mestre M; Montastruc JL;
Clin Neuropharmacol; 2003; 26(3):142-5. PubMed ID: 12782916
[TBL] [Abstract][Full Text] [Related]
12. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?
Hakala A; Tolppanen AM; Koponen M; Taipale H; Tanskanen A; Hartikainen S; Tiihonen M
J Am Med Dir Assoc; 2021 Jul; 22(7):1543-1547.e3. PubMed ID: 33460619
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease and antidepressant drug treatment: a case-register study.
Brandt-Christensen M; Garcia Lopez A; Mørkeberg Nilsson F; Kragh Andersen P; Vedel Kessing L
Parkinsonism Relat Disord; 2007 Oct; 13(7):406-10. PubMed ID: 17369074
[TBL] [Abstract][Full Text] [Related]
14. Incidence of antipsychotic use among community dwellers with and without Parkinson's disease.
Lilja S; Tolppanen AM; Koponen M; Hartikainen S; Tiihonen M
Parkinsonism Relat Disord; 2022 Oct; 103():69-72. PubMed ID: 36063707
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant use and risk of adverse outcomes in older people: population based cohort study.
Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J
BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886
[TBL] [Abstract][Full Text] [Related]
16. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample.
Chen P; Kales HC; Weintraub D; Blow FC; Jiang L; Mellow AM
J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):161-5. PubMed ID: 17712099
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators.
Forns J; Pottegård A; Reinders T; Poblador-Plou B; Morros R; Brandt L; Cainzos-Achirica M; Hellfritzsch M; Schink T; Prados-Torres A; Giner-Soriano M; Hägg D; Hallas J; Cortés J; Jacquot E; Deltour N; Perez-Gutthann S; Pladevall M; Reutfors J
J Affect Disord; 2019 Apr; 249():242-252. PubMed ID: 30780117
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.
Mills KA; Greene MC; Dezube R; Goodson C; Karmarkar T; Pontone GM
Int J Geriatr Psychiatry; 2018 Apr; 33(4):642-651. PubMed ID: 29235150
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease.
Koponen M; Lavikainen P; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Am Med Dir Assoc; 2019 Dec; 20(12):1488-1494.e3. PubMed ID: 31466934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
